Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes?
In recent decades, the impairment of cholesterol metabolism in the pathogenesis of Alzheimer's disease (AD) has been intensively investigated, and it has been recognized to affect amyloid β (Aβ) production and clearance, tau phosphorylation, neuroinflammation and degeneration. In particular, th...
Saved in:
Main Authors: | Erica Staurenghi (Author), Serena Giannelli (Author), Gabriella Testa (Author), Barbara Sottero (Author), Gabriella Leonarduzzi (Author), Paola Gamba (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis
by: Erica Staurenghi, et al.
Published: (2022) -
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer's Disease
by: Paola Gamba, et al.
Published: (2021) -
Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer's Disease
by: Erica Staurenghi, et al.
Published: (2024) -
24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1/PGC1α/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer's Disease
by: Gabriella Testa, et al.
Published: (2023) -
Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology
by: Qi Wu, et al.
Published: (2021)